ROTUOC
AGN

Regents of the University of California’s Allergan Inc AGN Stock Holding History

Regents of the University of California’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$977K Sell
10,800
-55,453
-84% -$4.98M 1.12% 31
2013
Q2 		$5.58M Buy
+66,253
New +$6.87M 3.01% 6

Other funds holding AGN

LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Regents of the University of California's AGN Position: Q3 2013 in Review

Regents of the University of California reduced its Allergan Inc (AGN) stake by 84% in Q3 2013, selling an estimated $4.98M and leaving 10,800 shares worth $977K. The position accounts for 1.12% of the portfolio, ranked #31.

Regents of the University of California first reported a position in AGN in Q2 2013 and has held it in 2 quarters since. The position peaked at $5.58M in Q2 2013. 642 funds tracked by Wall St. Rank hold AGN as of Q3 2013.

  • Regents of the University of California held 10,800 shares of Allergan Inc worth $977K as of Q3 2013.
  • Regents of the University of California sold 55,453 Allergan Inc shares in Q3 2013, an estimated $4.98M.
  • Allergan Inc made up 1.12% of Regents of the University of California's portfolio in Q3 2013, its #31 holding.
  • Regents of the University of California first reported a position in Allergan Inc in Q2 2013 and has held it in 2 quarters since.
  • Regents of the University of California's Allergan Inc position peaked at $5.58M in Q2 2013.
  • 642 funds tracked by Wall St. Rank held Allergan Inc as of Q3 2013.

Based on Regents of the University of California's 13F filing for Q3 2013, filed 28 Oct 2013.